Perry, J.J., Hackett, T.N., Bray, P.F. et al: "Laboratory Diagnosis of Multiple Sclerosis." Rocky Mountain Medicine Journal 70 (7) 42-44, 1973.
Bray, P.F., Perry, J.J., Hackett, T.N., et al: "Laboratory Confirmation of Multiple Sclerosis on a drop of Cerebrospinal Fluid." Connecticut Medicine 28 (8) 423-424, 1974.
Perry, J.J., Bray, P.F., Hackett, T.N.: "Comparison of Electroimmunodiffusion for Measurement of IgG in the Laboratory Diagnosis of Multiple Sclerosis, Clinical Chemistry 20: 1411-1443, 1974.
4.Cheung, L.Y., Lowrey, S.F., Perry, J.J., et al: Topical Effects of 16, 16 Dimethyl PGE2 on Gastric Acid Secretion and Mucosal Permeability to Hydrogen Ions in Dogs." GUT 19 (9): 775-778, September 1978.
Topol E and the GUSTO Investigators: "An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction," New England Journal of Medicine, 329:673-682, 1993.
Ross, A.M. and the GUSTO Angiographic Investigators: "The Effects of Tissue Plasminogen Activator, Streptokinase, or both on coronary artery patency, ventricular function, and Survival after Acute Myocardial Infarction." New England Journal of Medicine, 329:1615-1622, 1993.
Topol E and the GUSTO IIb Investigators: "A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes," New England Journal of Medicine, 335:775-782, (September 12), 1996
Waldo Al, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP and the SWORD Investigators: "Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction," The Lancet, Vol. 348, No. 9019, Pages 7-12, (Saturday 6 July), 1996
Betrieu, A; Phillips, H.; Ellis, S; and the GUSTO IIb Investigators: "A Clinical Trial Comparing Primary Coronary Angioplasty with Tissue Plasminogen Activator for Acute Myocardial Infarction," New England Journal of Medicine, 336:1621-1628, (June 5) 1997.
GUSTO III Investigators: "A Comparison of Reteplase with Alteplase for Acute Myocardial Infarction," New England Journal of Medicine, 337:1118- 1123, (October 16) 1997
Ross, A.M., Coyne, K.S., Reiner, J.S., et al.: "A Randomized Trial Comparing Primary Angioplasty With a Strategy of Short-Acting Thrombolysis and Immediate Planned Rescue Angioplasty in Acute Myocardial Infarction: The PACT Trial." Journal of the American College of Cardiology, 34: 1954- 1962, (December) 1999
Cohn, J.A., Tognani, G for the Valsartan Heart Failure Trial Investigators: "A Randomized Trial of the Angiotensin Receptor Blocker Valsartan in Chronic Heart Failure," NEJM 345:1667, December 6, 2001
Dahlof, B., Devereux, R.B., Kjeldsen, S.E., et al.: "Cardiovascular Morbidity and Mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol," The Lancet, 359: 995-1003, March 23, 2002
Lindholm, L.H., Ibsen, H., Dahlof, B. et al., "Cardiovascular Morbidity and Mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol," The Lancet, 359: 1004-1010, March 23, 2002
Kjeldsen, S.E., Dahlof, B., Devereux, R. B et al.., "Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients with Isolated Systolic Hypertension and Left Ventricular Hypertrophy." JAMA, 288:1491, September 25, 2002
Cheung, L.Y., Perry, J.J., Moody, F.G.: "Effect of Prostaglandin E on Gastric Mucosal Permeability to H+." Presented at the Tripartite Meeting of University Surgeons, September 1976, Philadelphia, PA.
Perry, J.J.: "3’5’ Cycle AMP Concentration in Cerebrospinal Fluid of Patients with Prolonged Coma." (Letter) New England Journal of Medicine, 296:56, 1977.
Perry, J.J.: "Coronary Angiography," video production, International Television Production, Inc., 1985
Perry, J.J.: "Prehospital initiated vs Hospital initiated Thrombolytic Therapy for Acute Myocardial Infarction," (letter) JAMA, 271, 6:426, 1994.
Lundergan, C.F., Reiner, J.S., Perry, J.J., Ross, A.M.: "Effect of Body Weight and (etc.)." Presented at 68th Scientific Session, American Heart Association, November 1995. Anaheim, California.
The Patient Rating score is based on responses given during the CAHPS Patient Experience Survey.Responses are measured on a 10 - point scale, with 10 being the best score. These scores are then translated to a 5 - point scale in order to display results in a 5 - star rating.Comments are also gathered from the same survey and displayed in their entirety with the exception of any language that may be considered slander, libel or contain private health information, which will be removed prior to publishing the comments.